Penumbra Return on Investment 2014-2022 | PEN
Current and historical return on investment (ROI) values for Penumbra (PEN) over the last 10 years.
Penumbra ROI - Return on Investment Historical Data |
Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
2022-09-30 |
$-0.04B |
$1.00B |
-3.94% |
2022-06-30 |
$-0.04B |
$1.00B |
-3.81% |
2022-03-31 |
$-0.03B |
$0.99B |
-2.96% |
2021-12-31 |
$-0.01B |
$0.98B |
-1.04% |
2021-09-30 |
$0.03B |
$0.71B |
4.36% |
2021-06-30 |
$0.00B |
$0.70B |
0.15% |
2021-03-31 |
$-0.03B |
$0.68B |
-4.09% |
2020-12-31 |
$-0.04B |
$0.67B |
-6.30% |
2020-09-30 |
$-0.03B |
$0.65B |
-4.48% |
2020-06-30 |
$0.01B |
$0.65B |
1.67% |
2020-03-31 |
$0.04B |
$0.52B |
14.80% |
2019-12-31 |
$0.05B |
$0.51B |
37.50% |
2019-09-30 |
$0.04B |
|
inf% |
2019-06-30 |
$0.01B |
|
inf% |
2019-03-31 |
$0.01B |
|
inf% |
2018-12-31 |
$-0.00B |
|
inf% |
2018-09-30 |
$-0.00B |
|
inf% |
2018-06-30 |
$0.02B |
|
inf% |
2018-03-31 |
$0.01B |
|
inf% |
2017-12-31 |
$0.00B |
|
inf% |
2017-09-30 |
$-0.00B |
|
inf% |
2017-06-30 |
$-0.01B |
|
inf% |
2017-03-31 |
$-0.01B |
|
inf% |
2016-12-31 |
$-0.00B |
|
inf% |
2016-09-30 |
$0.00B |
|
inf% |
2016-06-30 |
$0.01B |
|
inf% |
2016-03-31 |
$0.00B |
|
inf% |
2015-12-31 |
$0.00B |
|
inf% |
2015-06-30 |
$0.00B |
|
nan% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Instruments Manufacturing |
$9.289B |
$0.748B |
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
|